03:58 PM EST, 03/07/2024 (MT Newswires) -- Co-Diagnostics ( CODX ) said Thursday that its manufacturing and sales joint venture in India, CoSara Diagnostics, received clearance from the Central Drugs Standard Control Organization to manufacture and sell the influenza multiplex test kit Saraplex.

The Indian regulator approved the sale of the test to clinical laboratories for the detection and differentiation of Influenza A and Influenza B, according to the company.